Susquehanna International Group
GNCA

Susquehanna International Group’s Genocea Biosciences, Inc. GNCA Stock Holding History

Susquehanna International Group’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-127,600
Closed -$160K – 14624
2022
Q1 		$160K Sell
127,600
-13,100
-9% -$14.3K ﹤0.01% 11498
2021
Q4 		$163K Buy
140,700
+82,900
+143% +$124K ﹤0.01% 11702
2021
Q3 		$111K Sell
57,800
-49,700
-46% -$97.7K ﹤0.01% 12003
2021
Q2 		$252K Sell
107,500
-79,700
-43% -$192K ﹤0.01% 11136
2021
Q1 		$507K Sell
187,200
-49,800
-21% -$147K ﹤0.01% 9443
2020
Q4 		$574K Buy
237,000
+92,200
+64% +$210K ﹤0.01% 7984
2020
Q3 		$332K Buy
144,800
+111,900
+340% +$294K ﹤0.01% 8506
2020
Q2 		$76K Buy
+32,900
New +$75.8K ﹤0.01% 9626
2020
Q1 		– Sell
-10,100
Closed -$21K – 11386
2019
Q4 		$21K Buy
+10,100
New +$24K ﹤0.01% 9489
2019
Q3 		– Sell
-17,900
Closed -$70K – 11298
2019
Q2 		$70K Buy
+17,900
New +$93.4K ﹤0.01% 9749

Other funds holding GNCA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Susquehanna International Group's GNCA Position: Q4 2020 in Review

Susquehanna International Group sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2020, closing a stake of 56,458 shares — an estimated $129K sold.

Susquehanna International Group first reported a position in GNCA in Q2 2016 and held it in 12 quarters. The position peaked at $271K in Q1 2017. 39 funds tracked by Wall St. Rank hold GNCA as of Q4 2020.

  • Susquehanna International Group reported no remaining Genocea Biosciences, Inc. position as of Q4 2020 after selling out during the quarter.
  • Susquehanna International Group sold 56,458 Genocea Biosciences, Inc. shares in Q4 2020, an estimated $129K.
  • Susquehanna International Group first reported a position in Genocea Biosciences, Inc. in Q2 2016 and held it in 12 quarters.
  • Susquehanna International Group's Genocea Biosciences, Inc. position peaked at $271K in Q1 2017.
  • 39 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2020.

Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.